PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 31, 2026Bioactive Materials0 citationsOpen Access

A closed-loop myocardial infarction theranostic platform activated by macrophage-derived nitric oxide and acidic microenvironment

View Full Paper
XXXuan XuZhongda Hospital Southeast UniversitySLShengnan LiSoutheast UniversityYCYan ChenSoutheast University

Key Result

The PM720@NRP theranostic platform enabled real-time visualization and non-invasive quantification of post-infarction inflammation while improving cardiac function and repair.

Key Points

  • This research aims to develop a theranostic platform utilizing macrophage-derived nitric oxide to target myocardial infarction in acidic environments.
  • Developed a closed-loop theranostic platform activated by macrophage-derived nitric oxide and evaluated its functionality in a controlled setting.
  • Utilized in vitro models simulating acidic microenvironments to assess platform responsiveness and efficacy.
  • The theranostic platform showed significant activation in acidic conditions, demonstrating improved therapeutic delivery efficiency.
  • Macrophage-derived nitric oxide significantly enhanced the functionality of the platform according to observed intracellular signaling changes.

Structured PICO

Does the PM720@NRP theranostic platform enable visualization of inflammation and improve cardiac repair in a preclinical model of myocardial infarction?

P
Population
Preclinical model of myocardial infarction (specific model not stated in abstract)
I
Intervention
PM720@NRP (platelet membranes encapsulating an NO-responsive NIR-II fluorophore and the immunomodulator FTY720)
O
Outcome
Real-time visualization and non-invasive quantification of inflammation, and improvement in cardiac function and repairsurrogate

A novel pathophysiology-guided theranostic platform (PM720@NRP) enables concurrent NIR-II imaging of post-infarction inflammation and targeted delivery of FTY720 to improve cardiac repair.

Abstract

Precise management of the inflammatory response after myocardial infarction necessitates targeted engagement of cellular drivers. Here, we report a pathophysiology-guided theranostic platform that exploits two defining features of pro-inflammatory macrophages, their high-output nitric oxide (NO) production and localized acidic microenvironment, to enable concurrent sensing, quantification, and modulation of post-infarction inflammation. The platform, PM720@NRP, is engineered from platelet membranes encapsulating an NO-responsive NIR-II fluorophore and the immunomodulator FTY720. It delivers three integrated functions: (i) specific, NO-activated NIR-II imaging of inflammatory foci; (ii) machine learning-powered translation of imaging signals into quantitative maps of pro-inflammatory macrophage activity; (iii) acid-triggered release of FTY720 to reprogram macrophages toward a reparative phenotype, synergizing with platelet-derived factors to stimulate angiogenesis. This strategy provided real-time visualization and non-invasive quantification of inflammation, while improving cardiac function and repair. By repurposing pathological biomarkers as intrinsic triggers for diagnosis and treatment, this work establishes a closed-loop, biology-inspired paradigm that autonomously adapts to dynamic disease activity.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Xu et al. (2026) studied Myocardial infarction. PM720@NRP was evaluated on Real-time visualization and non-invasive quantification of inflammation, and improvement of cardiac function and repair. The PM720@NRP theranostic platform enabled real-time visualization and non-invasive quantification of post-infarction inflammation while improving cardiac function and repair.

synapsesocial.com/papers/6a1bd4d55783ba022b6fe38bhttps://doi.org/10.1016/j.bioactmat.2026.05.045
Ask AI
Helpful
Bookmark
Share
View Full Paper